Clinical Pharmacy
Sarah Vordenberg, PharmD, MPH
Associate Chair, Department of Clinical Pharmacy andClinical Associate Professor
College of Pharmacy
428 Church St
Ann Arbor, MI 48109-1065
2568A NUB
Role Overview and Bio
Sarah Vordenberg is a Clinical Associate Professor and Associate Chair of the Department of Clinical Pharmacy.
Research
Dr. Vordenberg’s research focuses on engaging adults in the medication decision-making process, specifically related to deprescribing in older adults and selection of safe and effective over-the-counter medications.
Patient education published in JAMA:
Polypharmacy and deprescribing
Nonprescription heartburn medications for adults
Oral non-prescription pain medications for adults
Teaching
Dr. Vordenberg is the course coordinator for the required first year P504 Pharmacy Practice Skills I course (fall semester) and P512 Self-Care course (winter semester).
Service
Dr. Vordenberg coordinates the College of Pharmacy engagement in the University of Michigan Student Run Free Clinic (UMSRFC) and is a member of the UMSRFC Advisory Board. She is also an active member of the American College of Clinical Pharmacy (Treasurer/Secretary for the Education and Training PRN). She is member of the MyDispense International Steering Committee and co-administers the MyDispense USA Community.
Research Interests
-
Deprescribing medications among older adults
-
Appropriate use of over-the-counter medications
-
Improving student learning via computer simulation
Awards
-
2015 ACCP MeRIT Scholarship Award, ACCP
-
2016 Poster Award: Barriers to Implementation of Community Pharmacy-Based Immunization Services in WayneCounty, Michigan, APhA-APPM Presentation Merit Award for Contributed Research at APhA
-
2016 Pharmacist of the Year, Hope Clinic
-
2017 Interprofessional Leadership Fellow, University of Michigan
-
2018 Student Appreciation Award , P1 Class
-
2019 Fellow, Michigan Pharmacists Association
-
2020 Teaching Excellence Award, University of Michigan College of Pharmacy
-
2022 Outstanding Reviewer, Journal of the American Pharmacists Association
-
2022 Academic Leadership Fellows Program, American Association of Colleges of Pharmacy
-
2023 Editorial Advisory Board, Journal of the American Pharmacists Association
-
2023 Outstanding Reviewer, Journal of the American Pharmacists Association
Selected Publications
Vordenberg SE, Kirch M, Singer D, Solway E, Roberts JS, Zikmund-Fisher BJ, Kullgren JT. Interest in medication deprescribing among US adults aged 50-80. J Gen Intern Med. 2024. DOI: 10.1007/s11606-024-08945-x
Hoffman CM, Vordenberg SE, Leggett AN, Akinyemi E, Turnwald M, Maust DT. Insights into designing educational materials for persons living with dementia: A focus group study. BMC Geriatr. 2024;380(24). DOI: 10.1186/s12877-024-04953-y
Vordenberg SE, Weir KR, Scherer AM, Jansen J, Schoenborn N, Todd A. Exploring different contexts of statin deprescribing: A vignette-based experiment with older adults across four countries. J Gen Intern Med. 2024; DOI: 10.1007/s11606-024-08698-7.
Weir KR, Shang J, Choi J, Rana R, Vordenberg SE. Factors important to older adults who disagree with a deprescribing recommendation. JAMA Netw Open. 2023;6(10):e2337281. DOI: 10.1001/jamanetworkopen.2023.37281.
Vordenberg SE, Rana R, Shang J, Choi J, Scherer AM, Weir KR. Reasons why older adults in three countries agreed with a deprescribing recommendation in a hypothetical vignette. Basic Clin Pharmacol Toxicol. 2023.
Vordenberg SE, Weir K, Jansen J, Todd A, Schoenborn N, Scherer AM. Harm and medication-type impact agreement with hypothetical deprescribing recommendations: A vignette-based experiment with older adults across four countries. J Gen Int Med. 2023.
Keller MS, Vordenberg SE, Steinman MA. Moving deprescribing upstream. J Gen Intern Med. 2022.
Rana R, Choi J, Vordenberg SE. Older adults’ willingness to consider deprescribing when experience hyperpolypharmacy. J Am Pharm Assoc. 2022.
Kim J, Kinney K, Nyquist M, Capellari E, Vordenberg SE. Factors that influence how adults select oral over-the-counter analgesics: A systematic review. J Am Pharm Assoc. 2022.
Choi J, Vordenberg SE. Older adults’ perceptions of deprescribing chronic benzodiazepines. J Am Pharm Assoc. 2021.
Vordenberg SE, Zikmund-Fisher BJ. Characteristics of older adults predict concern about stopping medications. 2020.